390 related articles for article (PubMed ID: 34650277)
1. Metabolic Messengers: tumour necrosis factor.
Sethi JK; Hotamisligil GS
Nat Metab; 2021 Oct; 3(10):1302-1312. PubMed ID: 34650277
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory properties of bone morphogenetic protein 4 in human adipocytes.
Baraban E; Chavakis T; Hamilton BS; Sales S; Wabitsch M; Bornstein SR; Ehrhart-Bornstein M
Int J Obes (Lond); 2016 Feb; 40(2):319-27. PubMed ID: 26228459
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus.
Hube F; Birgel M; Lee YM; Hauner H
Eur J Clin Invest; 1999 Aug; 29(8):672-8. PubMed ID: 10457150
[TBL] [Abstract][Full Text] [Related]
4. Periodontal inflammation and insulin resistance--lessons from obesity.
Nishimura F; Murayama Y
J Dent Res; 2001 Aug; 80(8):1690-4. PubMed ID: 11669476
[TBL] [Abstract][Full Text] [Related]
5. Journey from cachexia to obesity by TNF.
Argilés JM; López-Soriano J; Busquets S; López-Soriano FJ
FASEB J; 1997 Aug; 11(10):743-51. PubMed ID: 9271359
[TBL] [Abstract][Full Text] [Related]
6. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship.
Nishimura F; Iwamoto Y; Mineshiba J; Shimizu A; Soga Y; Murayama Y
J Periodontol; 2003 Jan; 74(1):97-102. PubMed ID: 12593603
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory pathways and insulin action.
Hotamisligil GS
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S53-5. PubMed ID: 14704746
[TBL] [Abstract][Full Text] [Related]
8. [Insulin resistance and cytokine, cytokine receptor].
Hamaguchi T; Nakajima H; Hanafusa T; Matsuzawa Y
Nihon Rinsho; 2000 Feb; 58(2):320-6. PubMed ID: 10707552
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.
Winkler G; Salamon F; Salamon D; Speer G; Simon K; Cseh K
Diabetologia; 1998 Jul; 41(7):860-1. PubMed ID: 9686931
[No Abstract] [Full Text] [Related]
10. The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance.
van Dierendonck XAMH; Sancerni T; Alves-Guerra MC; Stienstra R
J Biol Chem; 2020 Dec; 295(51):17535-17548. PubMed ID: 33453996
[TBL] [Abstract][Full Text] [Related]
11. Elevated Serum TNF-
Alzamil H
J Obes; 2020; 2020():5076858. PubMed ID: 32089876
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor, a key role in obesity?
Bulló-Bonet M; García-Lorda P; López-Soriano FJ; Argilés JM; Salas-Salvadó J
FEBS Lett; 1999 May; 451(3):215-9. PubMed ID: 10371192
[TBL] [Abstract][Full Text] [Related]
14. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.
Moller DE
Trends Endocrinol Metab; 2000 Aug; 11(6):212-7. PubMed ID: 10878750
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory cytokines and adipose tissue.
Coppack SW
Proc Nutr Soc; 2001 Aug; 60(3):349-56. PubMed ID: 11681809
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes.
Dominguez H; Storgaard H; Rask-Madsen C; Steffen Hermann T; Ihlemann N; Baunbjerg Nielsen D; Spohr C; Kober L; Vaag A; Torp-Pedersen C
J Vasc Res; 2005; 42(6):517-25. PubMed ID: 16155368
[TBL] [Abstract][Full Text] [Related]
17. Inflammation: the link between insulin resistance, obesity and diabetes.
Dandona P; Aljada A; Bandyopadhyay A
Trends Immunol; 2004 Jan; 25(1):4-7. PubMed ID: 14698276
[TBL] [Abstract][Full Text] [Related]
18. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
Martínez-Clemente M; Clària J; Titos E
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha: a key component of the obesity-diabetes link.
Hotamisligil GS; Spiegelman BM
Diabetes; 1994 Nov; 43(11):1271-8. PubMed ID: 7926300
[TBL] [Abstract][Full Text] [Related]
20. IL-15 that a regulator of TNF-α in patients with diabetes mellitus type 2.
Sánchez-Jiménez R; Alvarado-Vásquez N
Med Hypotheses; 2013 Jun; 80(6):776-7. PubMed ID: 23566659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
